Evidence map›Paper›PMID 28057756›Full record

ArticleThe Journal of biological chemistry2017

DHHC7 Palmitoylates Glucose Transporter 4 (Glut4) and Regulates Glut4 Membrane Translocation.

Keyong Du, Shoko Murakami, Yingmin Sun, Casey L Kilpatrick, Bernhard Luscher

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Palmitoylation in cardiovascular diseases: Molecular mechanism and therapeutic potential.International journal of cardiology. Heart & vasculature · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Mechanisms and functions of protein S-acylation.Nature reviews. Molecular cell biology · 2024
    Review
  18. Tryptophanylation of insulin receptor by WARS attenuates insulin signaling.Cellular and molecular life sciences : CMLS · 2024
    Article
  19. Genetic deletion of zinc transporter ZnTFrontiers in molecular neuroscience · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Keyong DuFrom the Molecular Oncology Research Institute, Tufts Medical Center, Boston, Massachusetts 02111 and kdu@tuftsmedicalcenter.org.ORCID 0000-0002-0284-3576
Shoko MurakamiDepartment of Biochemistry and Molecular Biology.
Yingmin SunFrom the Molecular Oncology Research Institute, Tufts Medical Center, Boston, Massachusetts 02111 and.
Casey L KilpatrickDepartment of Biochemistry and Molecular Biology.
Bernhard LuscherDepartment of Biochemistry and Molecular Biology.ORCID 0000-0003-1375-1906

Funding

GABAergic Control of Depression Related Brain StatesR01MH099851 · NIMH · PENNSYLVANIA STATE UNIVERSITY, THE · PI LUSCHER, BERNHARD · 2013 to 2019
$3.2M
GABAergic Synapse Assembly: Extrasynaptic GABAAR TargetingR01MH083911 · NIMH · PENNSYLVANIA STATE UNIVERSITY, THE · PI CHEN, GONG · 2010 to 2014
$1.8M
Clip R-59: a novel regulator of Akt signalingR01DK084319 · NIDDK · TUFTS MEDICAL CENTER · PI DU, KEYONG · 2010 to 2014
$1.7M
Clustering and Synaptic Targeting of GABA-A ReceptorsR01MH062391 · NIMH · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI LUSCHER, BERNHARD · 2002 to 2006
$1.5M
Use of a mouse model of anxious depression to assess the safety of pediatric antiRC1MH089111 · NIMH · PENNSYLVANIA STATE UNIVERSITY, THE · PI LUSCHER, BERNHARD · 2009 to 2010
$828k
Protein Trafficking Regulating the Formation of GABAergic SynapsesR56MH062391 · NIMH · PENNSYLVANIA STATE UNIVERSITY, THE · PI LUSCHER, BERNHARD · 2008 to 2008
$361k
ClipR-59: a novel regulator of Akt signalingR56DK084319 · NIDDK · TUFTS MEDICAL CENTER · PI DU, KEYONG · 2009 to 2009
$199k
NIDDK NIH HHS R01 DK084319NIDDK NIH HHS R56 DK084319NIMH NIH HHS R01 MH062391NIMH NIH HHS R01 MH083911NIMH NIH HHS R01 MH099851NIMH NIH HHS R56 MH062391NIMH NIH HHS RC1 MH089111
6 · The paper itself

Abstract

Insulin-dependent translocation of glucose transporter 4 (Glut4) to the plasma membrane plays a key role in the dynamic regulation of glucose homeostasis. We recently showed that this process is critically dependent on palmitoylation of Glut4 at Cys-223. To gain further insights into the regulation of Glut4 palmitoylation, we set out to identify the palmitoyl acyltransferase (PAT) involved. Here we report that among 23 mammalian DHHC proteins, DHHC7 is the major Glut4 PAT, based on evidence that ectopic expression of DHHC7 increased Glut4 palmitoylation, whereas DHHC7 knockdown in 3T3-L1 adipocytes and DHHC7 KO in adipose tissue and muscle decreased Glut4 palmitoylation. Moreover, inactivation of DHHC7 suppressed insulin-dependent Glut4 membrane translocation in both 3T3-L1 adipocytes and primary adipocytes. Finally, DHHC7 KO mice developed hyperglycemia and glucose intolerance, thereby confirming that DHHC7 represents the principal PAT for Glut4 and that this mechanism is essential for insulin-regulated glucose homeostasis.

Indexed as

3T3-L1 CellsAcyltransferasesAdipocytesAnimalsCell MembraneGlucose Tolerance TestGlucose Transporter Type 4HEK293 CellsHumansHyperglycemiaInsulinMiceMice, Inbred C57BLMice, KnockoutPalmitic AcidProtein TransportAcyltransferasesDhhc7 protein, mouseGlucose Transporter Type 4InsulinPalmitic AcidSlc2a4 protein, mouseadipose tissueDHHC proteingene knockoutglucose transportglucose transporter type 4 (GLUT4)membrane traffickingpalmitoylation.protein acylation

Identifiers

PMID28057756
PMCPMC5314192

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.